Gri bio announces partnership with the respiratory translational research collaboration to advance leading nkt regulation technology targeting earlier in the inflammatory cascade to modulate disease p

UK consortia brings together internationally recognized investigators in the UK’s leading centers of excellence to carry out experimental and early ...

October 17, 2023, 12:35 pm

Aditxt, inc. to present at 8th annual dawson james conference

Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12, 2023 Richmond, VA, Oct. 06, 2023 (GLOBE NEWSWIRE) —...

October 6, 2023, 12:00 pm

Gri bio announces publication of comprehensive invariant nkt (inkt) cell review in frontiers in immunology demonstrating a key role of type 1 inkt cells in modulating various fibrotic conditions

In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in th...

October 5, 2023, 12:45 pm

Coherent to demonstrate next-generation transceiver and semiconductor laser technology for 800g and 1.6t transmission in ai networks at ecoc 2023

The live demonstrations will include the following: OSFP 800G-FR4 DSP-based optical transceiver, highlighting 200G optical lanes OSFP 800G-DR8 linear ...

October 2, 2023, 5:05 am

Aditxt, inc. (nasdaq: adtx) announces participation at the h.c. wainwright 25th annual global investment conference september 11th-13th, 2023

RICHMOND, Va. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- #autoimmunity--Aditxt,® Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global in...

September 8, 2023, 7:05 am

Penumbra (pen) launches new technology for blood clot removal

Penumbra (PEN) launches Lightning Bolt 7, a new technology that can remove blood clots faster and more efficiently with ...

June 7, 2023, 8:48 am

Globus medical's (gmed) reflect correction system gets fda nod

Globus Medical's (GMED) REFLECT is intended to treat young children with progressive scoliosis, while preserving motion, stability and future ...

May 16, 2023, 3:57 pm

Cue biopharma reports first quarter 2023 financial results and recent business highlights

BOSTON, May 09, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of in...

May 9, 2023, 8:35 pm

Immunic presents data showing beneficial effects of imu-856 on gut health at digestive disease week 2023

Immunic Inc (NASDAQ:IMUX) said it has presented new clinical and pre-clinical data on the molecule IMU-856 at Digestive Disease Week (DDW) 2023 curren...

May 8, 2023, 8:17 am

Rapt therapeutics: potential strong upside ahead

RAPT Therapeutics, Inc. is a clinical-stage biotech developer of specific small molecules that can modulate...

March 30, 2023, 12:12 am

Fed's barr says now is the time to pay more attention to terminal rate

• We are not at a point where we can pay more attention to rate we are getting to and less on the pace
• It's smart to ...

  December 1, 2022, 8:42 pm

Tiziana life sciences publishes peer-reviewed research, showing intranasal administered drug for autoimmune diseases is safe in humans

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has published a scientific article in the peer-reviewed journal Frontiers in Immunology, showing a fav...

November 23, 2022, 11:41 am

Mindset pharma partners with the center for addiction and mental health for study comparing its novel compound msp-1014 with psilocybin

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has announced that it has partnered with Toronto-based psychiatric research hospital the Centre for Addicti...

June 22, 2022, 8:44 am

Skye bioscience enters research agreements with university of eastern piedmont and spanish research council

Skye Bioscience inc (OTCQB:SKYE) said it has signed new research agreements with the University of Eastern Piedmont (UPO) in Italy and the Spanish Re...

June 7, 2022, 7:40 am